page analyst certif import disclosur
media entertain rate target refresh facebook buy neutral biggest target chang
biotechnolog novel mg drug develop compel kol conserv market potenti physician
automot retail march light vehicl sale review nice rebound slow start year
biotechnolog spinraza set high bar competitor panel takeaway
medic suppli devic alcon reemerg valu spin implic novarti
bing watch
rate target refresh facebook buy neutral biggest target chang
publish april
messag wrap updat price target rate reflect outlook core trend current valuat note
optimist investor comfort level regulatori privaci risk facebook feel roku valuat accur reflect
opportun stream video remain rel cautiou tradit media compani histor benefit multipl revenu
stream consum behavior continu fragment larg competitor new entrant seek take share
page analyst certif import disclosur
 turnaround still appeal risk/reward less
downgrad neutral
publish april
messag downgrad buy neutral remov price target recent out-performance like
difm exposur continu posit view turnaround believ current near-peak valuat becom difficult justifi offer
limit room expans also see sever factor creat less favor risk/reward near term includ potenti below-consensu
guidanc higher execut risk relat turnaround initi lower likelihood acquisit
 still upsid potenti move year
publish april
messag see least three growth vector play layer cadenc next sever year note post
cday secondari offer per share march discuss vector present dcf analysi conclud despit
appreci stock ytd vs there still room potenti upsid reaffirm buy rate rais pt
sustain growth trajectori command higher multipl
hema beta-th clinic updat encourag earli
publish april
messag yesterday report encourag earli data hema beta-th program hema led peak
factor express normal rang week chromogen one-stag clot assay beta-th earli data show
led transfusion-independ sinc post-therapi increas fetal hemoglobin level stabl total hemoglobin level addit
takeaway
page analyst certif import disclosur
aprn neutral chang top guidanc re-affirmed
publish april
messag apron announc linda findley kozlowski previous next ceo current ceo brad dickerson ilia
papa depart follow transit period opinion chang leadership could reinvigor brand introduc new opportun
howev want recogn fiscal respons exercis mr dickerson leadership bring aprn adj ebitda profit current
cfo tim bensley remain aprn greatest potenti catalyst share remain profit new custom acquisit continu
 oktan highlight check
publish april
messag attend san francisco week host analyst session also host dinner partner
sidelin confer note present key highlight confer takeaway partner dinner check
qure manufactur tour takeaway
publish april
messag follow diseas genom medicin day boston visit uniqur tour manufactur facil
manag visit focus manufactur capabl huntington diseas program takeaway
novel mg drug develop compel kol conserv market potenti physician educ need
publish april
messag conjunct diseas genom medicin day boston host panel myasthenia gravi mg two
physician expert expert believ next-gen mg therapi develop carri promis diseas gener well control
current therapeut option leav limit market opportun next-gen therapi howev light real benefit novel therapi
demonstr top current standard-of-car believ disconnect physician percept next-gen mg therapi actual
potenti improv patient outcom light believ educ effort elucid risk/benefit profil novel drug target
physician commun might necessari takeaway panel highlight
page analyst certif import disclosur
march light vehicl sale review nice rebound slow start year
publish april
messag march us light vehicl sale came mn track well bbg consensu mn increas y/i highlight
new car incent spend remain modest spend per vehicl declin y/i mark seventh consecut month declin light truck
continu take share bp y/i light truck sale increas y/i sell day adjust passeng car sale trend show modest
declin y/i estim retail sale declin y/i march fleet sale increas hsd atp continu expand healthi pace
y/i larg consist februari price gain inventori level remain healthi start year current forecast full-year
repres declin driven new car afford headwind higher transact price rise interest rate
improv suppli late-model use vehicl lead consum trade search afford
spinraza set high bar competitor panel takeaway
publish april
messag conjunct diseas genom medicin day boston host panel lead expert larg
sma care center discuss chang treatment landscap spinal muscular atrophi sma discuss center around current approv sma
therapi spinraza up-and-com gene therapi develop novarti oral sma therapi develop roche/
key takeaway
alcon reemerg valu spin implic novarti
publish april
messag novarti schedul spin-off alcon busi dividend sharehold april help investor navig event
report walk thought alcon valuat implic novarti post separ analysi suggest fair valu alcon
per share impli enterpris valu busi ex-alcon novarti dcf valu compani chf impli
downsid current price result maintain neutral rate novn
page analyst certif import disclosur
publish april
detail upcom dominion atlant coast pipelin call
guggenheim ndr schedul pleas scroll
pjm/d/exc/nee/peg gener consum advoc request pjm board delay august auction april
sante /nee/d/duk lawmak say bill could go w/sante sale
ercot iso draw flak gener mainten delay march cold snap
segment econom concern news hulu explor new ad opportun bing watch
publish april
today top mind walk dead season nine final highest viewership sinc mid-season premier lowest viewership
season final date improv in-season stabil could bode well level rate futur season
disca/k morri updat domest expens growth time digit invest includ discoveri renew partnership
bbc uktv deal
zg fuller highlight potenti concern unit econom compani segment longer hold period smaller mark-up could
shift unit level profit
upcom event cb chief offic christina spade cb sport chairman sean mcmanu cb sport presid david berson head
investor relat david bank join guggenheim host investor meet ncaa men basketbal final four minneapoli april
 flyer pleas contact guggenheim repres addit detail
publish april
suspend termin coverag follow biotechnology/biopharmaceut compani note tabl page
page analyst certif import disclosur
page analyst certif import disclosur
inc
page analyst certif import disclosur
smart final store inc
page analyst certif import disclosur
explor product
page analyst certif import disclosur
